Physician profile
Mitchell G Davis
NPI 1528047149
$1,031.90
in general payments reported to CMS, 2019-2025
20 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.92 · 2020: $32.54 · 2021: $33.14 · 2022: $212 · 2023: $332 · 2024: $262 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $129.20 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $95.52 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $91.02 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $90.69 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $82.17 | 2019-2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.86 | 2022-2023 | Jardiance |
| Heartflow, INC. | $76.77 | 2023-2024 | Ffrct |
| Abiomed | $73.96 | 2024-2025 | Impella |
| Amgen INC. | $61.87 | 2020-2025 | Repatha |
| Merck Sharp & Dohme LLC | $40.05 | 2023-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.12 | 2023 | Lifevest |
| Edwards Lifesciences Corporation | $26.80 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Vital Connect, INC | $23.18 | 2024 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $21.06 | 2024 | |
| Abbott Laboratories | $18.59 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $18.45 | 2024 | Uptravi, Opsumit |
| Philips North America LLC | $17.27 | 2023 | |
| Scpharmaceuticals INC. | $16.34 | 2023 | |
| Esperion Therapeutics, INC. | $16.01 | 2025 | Nexletol |
| Amarin Pharma, INC. | $15.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.